Clinical Trial Update: Single Dose Lipopolysaccharide (LPS) Study In Healthy Volunteers [Phase 1]

View source ↗

Summary

Pfizer's Phase 1 trial evaluating a single-dose lipopolysaccharide (LPS) in healthy volunteers has completed. Chronic Obstructive Pulmonary Disease (COPD) is li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Lipopolysaccharide (LPS) (lipopolysaccharide)

Snippet

Sponsor: Pfizer | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | Status: COMPLETED